Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 161 - 180 out of 500 displayed.
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Reporting of transactions made by persons discharging managerial responsibilities in Orphazyme A/S

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Orphazyme ApS

IBA SA : DATA CONCERNING TRANSPARENCY

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Ion Beam Applications

AB Science announces the publication of Preclinical data showing that masitinb is capable of counteracting resistance to oncology treatments

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  AB Science SA

Bavarian Nordic Announces Exercise of Clinical Option by the US Government under Contract for Freeze-dried IMVAMUNE Smallpox Vaccine

Read more ››
By: Nasdaq / GlobenewsWire - 21 Nov 2017
Related companies:  Bavarian Nordic A/S | Bavarian Nordic GmbH

HelpMeSee To Demonstrate Eye Surgical Simulator at Comprehensive Cataract Conference 2017

MUMBAI, India, Nov. 21, 2017 /PRNewswire-USNewswire/ -- The International Society of Manual Small Incision Cataract Surgeons (ISMSICS) and HelpMeSee jointly announce a series of events for the upcoming Comprehensive Cataract Conference 2017 (CCC 2017), including demonstrations of HelpMeSee's... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  HelpMeSee

Elekta Debuts Magnetic Resonance Radiation Therapy System to Enable Precision Oncology Therapy at Radiological Society of North America Annual Meeting

CHICAGO, Nov. 21, 2017 /PRNewswire/ -- Elekta (EKTA-B.ST) is introducing its magnetic resonance radiation therapy (MR/RT) technology at the Radiological Society of North America (RSNA) 103rd Annual Meeting in Chicago November 26 to December 1. Elekta's MR-linac is the first system to enable simultaneous... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Elekta AB

AMCP Partnership Forum Identifies Key Opportunities to Improve Patient Financial Burden in Oncology and Shift to Value-Based Care Models

ALEXANDRIA, Va., Nov. 21, 2017 /PRNewswire-USNewswire/ -- Thought leaders representing managed care organizations, providers, patients, biopharmaceutical manufacturers and other stakeholders gathered recently to find solutions to the financial burden of oncology care on patients, while also improving... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

Avelas Biosciences to Present at Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 21, 2017 /PRNewswire/ -- Avelas Biosciences, Inc., a clinical stage oncology-focused company dedicated to improving cancer patient care from diagnosis through treatment, today announced that Carmine N. Stengone, president and chief executive officer, will present at the 29(th)... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Avelas Biosciences, Inc.

United States $6 Billion Insulin Delivery Devices Market Outlook to 2022 - Major Players are Insulet, Medtronic, Roche, Tandem Diabetes Care, Novo Nordisk, Eli Lilly, Sanofi & Owen Mumford

DUBLIN, November 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Glboal Glucose Monitoring Devices Markets, 2016-2024 - Growing Popularity of Smart, Compact, Digital, Ergonomic, and Wireless Glucose Monitors Drive Healthy Market Growth

DUBLIN, November 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Novus Detox Center Alerts Police and EMS to Risk of Accidental Fentanyl Overdose

NEW PORT RICHEY, Fla., Nov. 21, 2017 /PRNewswire-iReach/ -- Two law enforcement officers exhibited signs of an overdose after accidental contact with fentanyl earlier this year;(1) meanwhile, fentanyl-related deaths are skyrocketing--in a single year, synthetic opioid overdose fatalities have... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

MiMedx to Present at the 29th Annual Piper Jaffray Healthcare Conference

MARIETTA, Ga., Nov. 21, 2017 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare,... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  MiMedx Group, Inc.

Janssen Submits Application to U.S. FDA to Expand Indication for DARZALEX® (daratumumab) Combination Therapy for Patients with Newly Diagnosed Multiple Myeloma who are Transplant Ineligible

RARITAN, N.J., Nov. 21, 2017 /PRNewswire/ -- Janssen Biotech, Inc. today announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for DARZALEX(┬« )(daratumumab). This application seeks to expand the current indication,... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Janssen Biotech, Inc. | Janssen Research & Development, LLC | Janssen Research & Development, LLC

Global $12 Billion Fluid Management Systems Market 2017-2023 by Products, Application, End-users and Geography

DUBLIN, November 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

ITUS Will Hold Conference Call to Discuss its CAR-T Cancer Therapeutics Program

SAN JOSE, Calif., Nov. 21, 2017 /PRNewswire/ -- ITUS Corporation (NASDAQ: ITUS) reminds interested parties that it will be holding a conference call today at 2 p.m. Pacific/5 p.m. Eastern to discuss the launch of its Chimeric Antigen Receptor T-Cell (CAR-T) cancer therapeutics program.

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017

Early Adopters in Germany and the United Kingdom Are Prescribing Merck KGaA's Mavenclad as First-Line Induction Therapy for the Treatment of Multiple Sclerosis

EXTON, Pa., Nov. 21, 2017 /PRNewswire/ -- The multiple sclerosis (MS) market in the EU is poised to become even more fiercely competitive with the August 2017 approval of Merck KGaA's Mavenclad (cladribine) and imminent approval of Roche's Ocrevus (ocrelizumab). In a new report by Spherix Global... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

Innovaccer Deploys CIS(TM) Product Suite at StratiFi Health

SAN FRANCISCO, Nov. 21, 2017 /PRNewswire/ -- StratiFi Health, a physician services and population health organization, is further advancing their population health management initiatives in partnership with Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017

Probiotics and Prebiotics Food and Beverage New Product Trends 2017 - Cutting Edge, Taking Root & Going Mainstream

DUBLIN, November 21, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Ascendiant Capital Markets LLC | RBC Capital Markets | KeyBanc Capital Markets

Neurocrine Biosciences to Present at the 29th Annual Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 21, 2017 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the 29th Annual Piper Jaffray Healthcare Conference at 12:00 p.m. ET on Tuesday, Nov. 28, 2017, in New York City. Timothy P. Coughlin, Vice President Finance of Neurocrine Biosciences, will present... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
Related companies:  Neurocrine Biosciences, Inc.

Recent Chart Audit Reveals Switching Rheumatoid Arthritis Patients to Roche/Genentech's RoActemra (Actemra) is Significantly More Common in the EU5 than it is in the US

EXTON, Pa., Nov. 21, 2017 /PRNewswire/ -- Analysis of over 2,200 RA patients in the US and EU5 (France, Germany, Italy, Spain, and the United Kingdom) reveals clear differentiation in treatment patterns amongst rheumatoid arthritis (RA) patients who have recently switched brands. US rheumatologists... Read more ››

By: PR Newswire Association LLC. - 21 Nov 2017
«  1  2  3  4  5  6  7  8 9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑